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Available online 18 July 2016Bone losses are common as a consequence of unloading and also in patients with chronic obstructive pulmonary
disease (COPD). Although hypoxia has been implicated as an important factor to drive bone loss, its interaction
with unloading remains unresolved. The objective therefore was to assess whether human bone loss caused by
unloading could be aggravated by chronic hypoxia.
In a cross-over designed study, 14 healthy young men underwent 21-day interventions of bed rest in normoxia
(NBR), bed rest in hypoxia (HBR), and hypoxic ambulatory conﬁnement (HAmb). Hypoxic conditions were
equivalent to 4000 m altitude. Bone metabolism (NTX, P1NP, sclerostin, DKK1) and phospho-calcic homeostasis
(calcium and phosphate serum levels and urinary excretion, PTH)were assessed from regular blood samples and
24-hour urine collections, and tibia and femur bone mineral content was assessed by peripheral quantitative
computed tomography (pQCT).
Urinary NTX excretion increased (P b 0.001) to a similar extent inNBR andHBR (P=0.69) and P1NP serum levels
decreased (P=0.0035) with likewise no difference between NBR and HBR (P=0.88). Serum total calcium was
increased during bed rest by 0.059 (day D05, SE 0.05mM) to 0.091 mM (day D21, P b 0.001), with no additional
effect by hypoxia during bed rest (P=0.199). HAmb led, at least temporally, to increased total serum calcium, to
reduced serum phosphate, and to reduced phosphate and calcium excretion.
In conclusion, hypoxia did not aggravate bed rest-induced bone resorption, but led to changes in phospho-calcic
homeostasis likely caused by hyperventilation. Whether hyperventilation could have mitigated the effects of
hypoxia in this study remains to be established.







The risk of bone loss in response to unloading by experimental bed
rest [1,2] and space ﬂight [3] is widely recognized. Such bone losses
occur predominantly in the legs and not in the upper extremities [2–
5]. Loading forces in the lower extremities are typically low in space
[6], but exercises with sufﬁciently large musculoskeletal loading pre-
vent the well-established bed rest-induced bone losses [7–9]. However,
even though the primary origin may be of a mechanical nature, boneedicine, Linder Höhe 1, 54117
. This is an open access article underlosses in astronauts and immobilized patients are likely modulated by
the endocrine environment and the milieu intérieur.
The interaction between hypoxia and unloading is under-studied,
but has become a relevant topic in space medicine. While originally
perceived as a countermeasure [10], the current interest arises from
atmosphere deﬁnition for next generation spacecrafts: atmospheres
equivalent to e.g. 3000 m will be used to avoid decompression sickness
and thus to facilitate extra-vehicular activity. This perspective raises
new questions about potential interactions between hypoxia and
unloading with regards to bone and beyond.
Speciﬁcally, arterial hypoxemia and hypercapnia, as a consequence
of reduced alveolar ventilation and the resultant alveolar hypoxia, are
commonly observed in many patient groups that are inactive, and ren-
dered hypoxic by their illness, most prominently patients sufferingthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
131J. Rittweger et al. / Bone 91 (2016) 130–138moderate to severe chronic obstructive pulmonary disease (COPD) [11].
In these patients, arterial hypoxemia leads to pulmonary remodeling,
causing emphysema and pulmonary hypertension. Anemia caused by
chronic systemic inﬂammation is associated with poor prognosis [12],
and cachexia further increasesmortality in these patients. Of note, initial
stages of COPD typically present with normocapnia [13].
Osteoporosis is also prevalent in chronic obstructive pulmonary
disease (COPD) [14]. The factors that have been implicated in its etiolo-
gy include lack of physical activity, vitamin-D deﬁciency, hypogonadism
[15] and smoking [16], and use of high-dose corticosteroid therapy,
which can be required in severe COPD exacerbations [17,18]. Notably,
hypoxia at 1 kPa reduces, in vitro, osteoblastic secretion of sclerostin
via Mef2 and Smad [19], which must be expected to counteract bone
loss. On the other hand, reducing PO2 from 20 kPa to 2 kPa and
0.2 kPa in vitro leads to marked increase in osteoclastogenesis and a de-
crease in osteoblastic differentiation [20,21]. Thus, it seems undeter-
mined from in vivo studies alone whether hypoxia promotes bone loss
or bone formation.
To address the problem regarding interaction of hypoxia and inactiv-
ity, the PlanHab study [22] was implemented as a 21-day bed rest study
in cross-over design with a broad spectrum of physiological endpoints.
Although the primary aim of the project was to investigate the effects
of the anticipated hypoxic environments in future planetary habitats
on physiological systems, the results are relevant for Earth-bound pa-
tient populations that are inactive and hypoxic. Healthy young male
subjects underwent bed rest in normoxic conditions (NBR), bed rest in
hypoxic conditions (HBR) at altitude equivalent of 4000m, and hypoxic
ambulatory conditions (HAmb) at the same altitude equivalent as HBR.
The HAmbwas meant to reveal the effects of hypoxia per se by analysis
of time-effects. Within the PlanHab project, a sub-study was organized
to explore effects upon bone metabolic response to quantify potential
aggravation of bed rest-induced bone losses by hypoxia. However, one
also has to consider that hypoxia induces hyperventilation and thus
respiratory alkalosis. This may positively affect bone metabolism via a
renal effect [23] and also via a direct effect upon osteocytes [19]. Accord-
ingly, no speciﬁc hypothesis was made as to whether hypoxia would
aggravate or mitigate bed rest-induced bone losses.
2. Materials and methods
The present sub-study within the PlanHab project (registration
number NCT02637921 at www.ClinicalTrails.gov) addressed bone
metabolism and calcium homeostasis through biochemical analysis
of blood and urine samples. In addition, it assessed leg bone structural
changes by peripheral quantitative computed tomography (pQCT).
The detailed outline of the PlanHab project is given elsewhere [22],
and we only brieﬂy explain the project's general features here.
2.1. Study design and setting
The PlanHab study was performed between October 2012 and
December 2013 at the hypoxic facility at the Olympic Sport Center
Planica in Rateče, Slovenia, located at 940 m of altitude. The study was
conducted according to the ESA plan for standardization of bed rest
studies [24], and was organized in 3 successive experimental cam-
paigns. Each campaign consisted of 5 days of baseline data collection
(BDC) during which subjects were ambulant, 21 intervention days
(normoxic bed rest, hypoxic bed rest, or hypoxic ambulation), and
5 days of follow-up. For the latter, operational days are designated by
‘R + i’, meaning i days after re-ambulation. For BDC, operational days
are indicated by ‘BDC-n’, meaning n days before the onset of bed rest.
Prior to commencement, the study had received approval by the
National Committee for Medical Ethics at the Ministry of Health of the
Republic of Slovenia. In addition to the present sub-study, other sub-
studies focused upon cardiorespiratory, muscular, immunological and
thermoregulatory effects.2.2. Test subjects
Inclusion and exclusion criteria for the study complied with the
European Space Agency's standardization plan for bed rest studies
[24] and aimed at selecting subjects who could safely undergo bed
rest (e.g. exclusion of people with osteoporosis, with blood clotting dis-
orders, history of deep vein embolism, lower back pain, and respiratory
disorders). In addition, subjects were also excluded from this study if
they had been exposed to altitudes N2000 m, two months prior to
study commencement. Fourteen young healthy men participated in
this study, with a mean age of 26.4 (SE 1.4) years, a height of 179.6
(SE 1.4) cm, a mass of 75.9 (SE 2.8) kg and a body mass index of 23.5
(SE 0.8) kg/m2.
2.3. Bed rest and environmental protocol
Environmental conditionswere controlled (ambient temperature=
24.4 ± 0.7 °C, relative humidity = 53.5 ± 5.4%) or assessed (ambient
pressure 91.2± 5.3 kPa) throughout all campaigns. Capillary oxyhemo-
globin saturation (SpO2) was measured daily at 7:00 with a 3100
WristOx device (Nonin Medicals, Minnesota, USA) and also as part of
a sleep polysomnographic study. To the latter purpose, full ambulatory
polysomnography (Nicolet One, Viasys, Healthcare, Neurocare, Madi-
son, WI, USA) was performed using standard setups [25] after subjects
had spent at least two nights in the facility; during each campaign, mea-
surements were conducted on three occasions: 1) baseline data collec-
tion day 3, 2) night 1 (N1), and 3) night 21 (N21) of the intervention.
The light:dark cycle was set to 16:8 h, with bed time between 23:00
and 7:00.
During the bed rest phase of NBR and HBR campaigns subjects were
conﬁned to bed in the horizontal position for 24 h/day, and all activities
of daily living took place in bed. One pillow was allowed for head sup-
port. Showers were taken on a speciﬁc gurney, and hospital equipment
was used for bowel movements and urine collection. Compliance with
the bed rest protocol was ascertained by supervision through members
of staff and through closed-circuit television. No physical activity was
allowed during NBR and HBR campaigns, except for changing position
between supine, prone and lateral.
During HAmb, subjects were conﬁned to the hypoxic area, but
remained ambulatory and out of bed during the day. In order to repli-
cate their habitual bone loading during the conﬁnement periods, sub-
jects performed low-level physical activity in two 30-minute bouts
per day. This came as stepping, cycling and dancing exercise. Telemetric
heart rate monitoring was used to achieve the targeted heart rate
(123 ± 4 beats min−1) during the exercises, which was set to the
heart rate observed at 50% peak power output assessed at the onset of
the intervention.
During HBR and HAmb campaigns, normobaric hypoxia was gener-
ated within the hypoxic area by a vacuum pressure swing adsorption
system (b-Cat, Tiel, the Netherlands). Regulation of O2 concentration
was actuated within each room at 15-minute intervals. For safety rea-
sons, subjects wore portable O2 sensors (Rae PGM-1100, California,
USA) at all times.
2.4. Diet
As reported earlier [26], the subjects were provided with an individ-
ually tailored, standardized and controlled diet throughout each inter-
vention. Energy requirements were assessed with the Harris-Benedict
method [27], and correction factors of 1.4 and 1.2 were used to account
for activity levels in the ambulatory phases and the bed rest phases, re-
spectively. In addition to setting the intake of fat to 30% of energy and
the intake of protein to 1.2 g per kg body mass, sodium intake was set
at b3500 mg per day. Subjects were supplemented with 1000 IU vita-
min D3 per day. Fluid intake was ad libitum, but subjects were encour-
aged to drink at least 28.5 mL per kg per day. Importantly, menu plans
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quantity according to activity factors.
2.5. Peripheral quantitative computed tomography
pQCT scanswere obtained from the shank and from the thigh on the
6th day of baseline data collection (BDC-6), on the 2nd, the 10th and the
21st intervention day (D02, D10 and D21, respectively), and at 14 days
of follow-up (R+ 14). Scanswere obtained as previously described [28,
29] by scout-viewing the tibio-talar joint and the knee joint in the fron-
tal plane, to identify the distal and proximal tibia joint surfaces, and the
distal femur surfaces as landmarks. Horizontal scans were then taken at
4%, 14%, 38%, and 66% of the tibia (assessed from its distal end, and at 4%
and 33% of the femur.
2.6. Biological sample collections
Twenty-four hour urine collections were obtained on days BDC-2,
BDC-1, D01, D02, D03, D04, D08, D10, D12, D14, D16, D18, D21, R + 2,
R + 3 and R + 4. 24-hour urine collection started at 07:00 h. Urine
voids were kept until ﬁnal pooling in the 24-hour urine pool. Aliquots
were stored at−20 °C, with calcium and phosphorous aliquots being
acidiﬁed before freezing.
Fasting blood samples were collected from an antecubital vein at
07:00 h on days BDC-2, BDC-1, D02, D05, D10, D14 and D21. Whole
blood was centrifuged (3000 rpm, 4 °C, 10 min) after coagulation, and
serum was distributed in 1.5 mL Eppendorf tubes and immediately
frozen at −20 °C (PINP, FGF and Klot) and −80 °C (bAP, Scle, Ocal,
PTH and 25-OH-D) until analysis.
2.7. Biochemical analysis
Serum levels of bone speciﬁc alkaline phosphatase (bAP), parathyroid
hormone (PTH) and 25-Hydroxyvitamin D (25-OH-D) were assessed
by using commercially available radioimmunoassays (RIA); (bAP, PTH:
Immunotech, Prague, Czech Republic; 25-OH-D: DiaSorin, Saluggia,
Italy). Serum levels of Procollagen-I-N-terminal propeptide (P1NP)
were assessed by using RIA assays (Orion Diagnostica, Espoo, Finland).
Regulators of bone metabolism, namely Dickkopf-related protein 1
(DKK1) and Sclerostin (SOST) were analyzed by enzyme-linked immu-
nosorbent assay (ELISA) (DKK1: Biomedica, Vienna, Austria, SOST:
Quidel/TECOmedical, San Diego, USA). Inter-assay CV and intra-assay
CV were assessed as follows: bAP (4.1%, 5.5%), PTH (5.85%, 7.95%), 25-
OH-D (N/A*, 12.5%), P1NP (2.45%, 2.05%), DKK1 (6.3%, 5.4%).
Serum and urinary calcium and phosphate were analyzed by an
automated analyzer for clinical chemistry by spectrophotometric enzy-
matic colorimetric tests (COBAS INTEGRA 400 plus, Roche Diagnostics,
Mannheim, Germany), at wavelengths of 340/378 nm for calcium and
at 700/340 nm for phosphorus. N-terminal telopeptide (UNTX) as a
distinct marker for bone resorption was detected via ELISA measure-
ment in urine samples (Immunodiagnostic Systems Ltd., Bolden, UK).
Inter-assay CV and intra-assay CV for UNTX were 5.75% and 3.55%,
respectively.
2.8. Respiratory gas measurements
End-tidal carbon dioxide concentration was measured on day BDC-5
while exposed to a normoxic environment and on day D17 of each inter-
vention, breathing the prevailing gasmixture,whichwas either normoxic
(NBR) or hypoxic (HBR, HAmb).Measurementswere performedwith the
subject resting supine and breathing via an oronasalmask and a two-way
respiratory valve that was connected to a capnograph (Quark CPET,
Cosmed, Rome, Italy). Breath-by-breath values of end-tidal partial pres-
sure of CO2 (PETCO2) were averaged during the last min of a 15-minute
period of motionless rest. Prior to each experiment, the capnograph
was calibrated using two different gas mixtures.2.9. Data processing
The volumes of the 24 h urine samples were multiplied by the urine
concentrations of NTX, Ca, and P to yield the 24 h urinary excretion of
these compounds. pQCT image analyses were performed with the inte-
grated XCT software (version 6.20B). Regions of interest (RoIs) around
the tibia and ﬁbula in shank scans, and around the femur in the thigh
scans, were outlined by a rater blinded to the nature of the data. In the
epiphyseal/metaphyseal scans, very narrow RoIs were deﬁned, as these
sites require relatively low segmentation thresholds, in order to suppress
soft tissue contributions to bone data. The segmentation thresholdswere
individualized so that the highest threshold was used that was still able
to achieve a clean segmentation. For each individual and site, the same
threshold was used for image analysis at the different time points. For
the diaphyseal RoIs, simple rectangular RoIs were used and the segmen-
tation thresholdwas set to 650mg/cm3 [30,31]. All RoIswere checked by
one of the authors as second expert (UM), and images were then
automatically processed with the XCT software by using the ‘loop’ and
‘automatic analysis’ tools. From the resulting database, we extracted
the bone mineral content (BMC) as TOT_CNT.
2.10. Statistical analyses
Statistical analyses were carried out using the R-environment
(version 3.1.1 for the 64-bit Windows platform, www.r-project.org).
Data were analyzed following the intent-to-treat principle and are
given as best linear unbiased predictors (BLUPs) and their SE, expressed
as percent of BDC values of NBR and HAmb campaigns in the text and in
Table 2, and as means and standard errors (SE) in the ﬁgures. The level
for statistical signiﬁcance was set to 0.05.
To address the primary goal of the study, namely to test for hypoxia
effects during bed rest, linear mixed effect (LME) models were con-
structed with time and condition (either NBR or HBR) as ﬁxed effects
and subject as random effect, and with the HAmb data excluded. The
HAmb data were then used to address secondary goal of the study, via
LMEswith time asﬁxed effect and subject as randomeffect. LMEmodels
were optimized according to Akaike's information criterion (see p. 353
and p. 652 in [32]). Data were box-cox transformed when non-linear
quantile-quantile plots or heteroscedacity was found. Data from the
baseline data collection (BDC) phase were lumped together. Models
for statistical testing of the primary hypothesis were simpliﬁed in a
step-wise manner. Firstly, the time ∗ condition interaction term was
discarded where justiﬁed by non-signiﬁcance and Akaike's criterion,
and the condition term was discarded in the next step. Any signiﬁcant
effects were followed up with treatment contrasts, using BDC and NBR
as reference.
3. Results
3.1. Study conduct and subjects
Subjects generally tolerated the interventions well. However, one
subject showed signs of acute mountain sickness at the onset of HBR
and was moved to a room in which the hypoxia was equivalent to
approximately 3000 m altitude. Thereafter, the simulated altitude was
increased by 500m per day for this subject, until attainment of the req-
uisite altitude of 4000 m. For this subject, the same protocol was used
during the subsequent HAmb campaign. Two subjects did not return
for the 3rd campaign, and one subject had to be withdrawn during the
3rd campaign because of health problems unrelated to the study.
Average day-time SpO2 amounted to 97.1 (SE 0.1) % duringNBR, and
was reduced to 88.2 (SE 0.2) % in HBR and to 87.9 (SE 0.2) % in HAmb
(both P b 0.001). These day-time SpO2 values tended to recover during
the experimental phases of both the HAmb and HBR trials (P b 0.05).
Night-time SpO2 amounted to 94.3 (SE 0.4) during the ﬁrst night of
NBR, which was lowered to 83.2 (SE 0.5) % and 81.6 (SE 0.5) % during
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day-time SpO2 values, night time values tended to recover for HBR
and HAmb over time (P b 0.001). Statistical analysis yielded a
time ∗ condition interaction for PCO2 (see Table 1), indicating lowered
PETCO2 and thus hyperventilation during intervention phases of HBR
and HAmb. Serum levels of 25-OHD during BDC of the different cam-
paigns were 14.2 (SE 1.3) ng·mL−1 for NBR, 16.2 (SE 0.6) ng·mL−1
for HBR and 13.8 (SD 2.2) ng·mL−1 for HAmb. 25-OHD levels were
comparable across conditions (P = 0.25) and ranged between 7.0 and
21.3 ng/mL.
3.2. Bone mineral content
NBR and HBR data revealed the expected reductions in BMC, which
were observed on day R+14 at all, but the 33% femur site (see Table 2).
Additionally, the 4% femur site depicted bone loss also on day BR21
(P= 0.020). Conversely, and counter-intuitively, statistical analysis in-
dicated increases over baseline BMC values at the 66% tibia site on D10
and D21 (P= 0.0058 and P= 0.0030, respectively).
With regards to hypoxia effects, no time ∗ hypoxia interaction was
observed in NBR and HBR data for the tibia and for the 33% femur site
(P = 0.058 for the 4% femur site, and P N 0.5 for all other sites, see
Table 2). HAmb data yielded small but signiﬁcant increases in BMC at
the 66% tibia site and at the 33% femur site, which, however, was limited
to the 10th day of HAmb only (see Table 2).
3.3. General effects upon bone metabolism
NBR and HBR data likewise yielded expected bed rest effects for all
measures of bone metabolism (P = 0.004 for P1NP and all other
P b 0.001, see Table 3). Therewere generally nomain effects of condition
in these bed rest data, except for PTH (P = 0.045) and DKK1 (P =
0.0052). However, these latter effects were insubstantial, so that base-
line conditions were comparable between campaigns.
With regards to hypoxia, NBR and HBR data revealed time ∗ hypoxia
interactions only for serum levels of PTH (P b 0.001), for urinary excre-
tion of calcium (P=0.029) and of phosphate (P=0.0010). Conversely,
HAmbdata depicted signiﬁcant effects of time formost variables, except
for serum levels of P1NP and NTX excretion. Taken together, therefore,




The expected increase during bed rest (see Fig. 1) was signiﬁcant for
all days from D04 to R + 3 (P=0.047 for D04 and P b 0.01 for all other
days), amounting to up to 79% (SE 11.2%). In addition, we unexpectedly
observed a decrease at D01 by 32.3% (P=0.001), and an increase by the
sameamount at D02 (P=0.0065). Notably, therewasno time ∗hypoxia
interaction (P = 0.69) in NBR and HBR data, but a trend for time in
HAmb data (P= 0.072).
3.4.2. Calcium excretion
Increases were observed during NBR from day D08 until R + 3
(all P ≤ 0.01, see Fig. 1) by up to 69% (SE 12%). A time ∗ hypoxiaTable 1
End-tidal CO2 partial pressure (PetCO2) at rest, assessed at BDC andD17 in each condition.
Day NBR HBR HAmb
BDC 33.7 (2.5) 34.2 (1.9) 34.4 (2.2)
D17 33.4 (1.8) 26.9⁎⁎⁎ (1.5) 27.3⁎⁎⁎ (1.9)
⁎⁎⁎ Denotes signiﬁcant time ∗ condition interaction with P b 0.001.interaction indicated attenuation of increased calciumexcretion byhyp-
oxia on days D08 and D10 of HBR (P b 0.001 and P=0.034, respective-
ly), but not during the second half of HBR (all P ≥ 0.18). Calcium
excretion was decreased between D04 and D14 of HAmb (all
P b 0.017), with the decrements ranging between28% and 37% (SE 13%).
3.4.3. Phosphate excretion
NBR data showed increases in phosphate excretion by 30%, by 26%
and by 31% (SE 13%) on days D02, D04 and D08 of bed rest, respectively
(all P b 0.04). Strong opposing time ∗ hypoxia interaction effects were
found on days D01 and D02, and a trend on day D04 (P = 0.0059,
P = 0.0036, and P = 0.09, respectively), which implied decreases in
phosphate excretion by −47%, by −51% and by −28%, respectively.
HAmb data yielded decreased phosphate excretion on days D01, D02,
D03, D04 and D10 of HAmb (all P ≤ 0.030) by down to−38%, but in-
creases of comparable magnitude on days R + 2 and R + 3 after
HAmb (both P= 0.002).
3.5. Serum biochemistry
3.5.1. P1NP levels
Decreases on days D10, D14 and D21 of NBR (P= 0.003, P= 0.021
and P= 0.043, respectively) amounted to−10.6%,−8.3% and−7.3%
(SE 3.8%). Neither was a time ∗ hypoxia interaction observed in NBR
and HBR data (P= 0.88), nor a time effect in HAmb data (P= 0.97).
3.5.2. bAP levels
Contrasting with P1NP levels, there were increases in bAP levels
by 10.0% to 13.0% (SE 3.5%) between day D02 and day D14 of NBR (all
P b 0.005). No time ∗ hypoxia effect was found in NBR and HBR data
(P = 0.97), and increases by 8.6% to 12.0% were found on D02, D05
and D14 of HAmb (all P ≤ 0.05).
3.5.3. Calcium levels
A main effect of time in NBR and HBR data indicated increases on
all days from D02 to D21 (all P b 0.001) by 0.059 to 0.091 mM (SE
0.009 mM). There was no time ∗ hypoxia interaction (P = 0.83).
HAmb data revealed a quantitatively similar effect of time as HBR
data, with increases on all but the 14th day of HAmb (all P ≤ 0.022).
3.5.4. Phosphate levels
Increases on days D05, D10, D14 and D21 (all P b 0.001) by
0.081 mM to 0.16 mM (SE 0.02 mM) were observed in NBR and HBR
data, but no time ∗ hypoxia interaction (P = 0.73). Conversely, HAmb
data yielded signiﬁcant decreases on D02, D05, and D21 days of HAmb
(P b 0.05) by 0.064 mM to 0.224 mM (SE 0.032 mM).
3.5.5. PTH levels
NBR and HBR data yielded the expected decrease on all days
(all P b 0.001) by down to −31% (SE 3%) on D21. Trends for
time ∗ hypoxia interactions indicated mitigation of the PTH decrease
on days D10 and D14 (P = 0.069 and P = 0.077, respectively), and a
signiﬁcant time ∗ interaction effect was found on day D21 (P b 0.001).
During HAmb, PTH levels were increased on D14 (P = 0.0043) by
13%, and a trend indicated a decrease on D05 (P= 0.06).
3.5.6. Sclerostin levels
NBR andHBR data yielded increases for all days fromD02 to D21 (all
P b 0.001) by 9.9% to 25.9% (SE 2.6%). No time ∗ hypoxia effectwas found
(P=0.61). Notably, sclerostin was also increased on D02, D10 and D14
of HAmb (all P b 0.01) by 8.5% to 11.7% (SE 3.2%).
3.5.7. DKK1 levels
Increases were observed during NBR and HBR on days D05, D10 and
D14 (all P b 0.02) by 18.3 to 40.5% (SE 7.8%), with a trend towards an in-
crease also on day D21 (P= 0.053). No time ∗ hypoxia interaction was
Table 2
Changes in BMC as obtained by pQCT for the 4 tibial and the 2 femural measurement sites. The presented values are best linear unbiased predictors (BLUPs) and their standard errors, as
obtained by mixed effect analysis, expressed in percent of the BDC values in NBR and HAmb campaigns, respectively.
Bed rest BR: Hypoxia interaction Ambulatory hypoxia
Effect (SE) P-value P-value Effect (SE) P-value
Tibia 4% R + 14:−1.37% (0.26%) b0.001 0.66 – 0.16
Tibia 14% R + 14:−0.30% (0.09%) 0.0044 0.85 – 0.41
Tibia 38% R + 14:−0.38% (0.13%) 0.032 0.60 – 0.26
Tibia 66% D10: +0.23% (0.08%)
D21: +0.25% (0.08%)
R + 14:−0.35% (0.08%)
b0.001 0.86 D10: +0.37% (0.11%) 0.0073
Femur 04% D21:−0.39% (0.16%)
R + 14:−0.55% (0.16%)
0.0031 0.058 – 0.38
Femur 33% – 0.096 0.95 D10: +0.36% (0.12%) 0.024
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HAmb (all P b 0.05) by 24.5% (SE 8.9%) and by 31.2% (SE 8.6%),
respectively.
4. Discussion
This study has explored the effects of hypoxia upon bed rest-induced
bone losses and calciumhomeostasis during a 21-day bed rest paradigm
in young healthymen at a simulated altitude of ~4000m. The most im-
portant ﬁnding of this study is that time ∗ hypoxia interactions during
bed rest were non-signiﬁcant for bone resorption (urinary NTX excre-
tion), but highly signiﬁcant for calciumhomeostasis (serumPTH, urinary
excretion of calcium and phosphate). To the best of our knowledge, the
only preceding study was performed ﬁve decades ago by Lynch et al.
[10]. That study used hypobaric (as opposed to normobaric) hypoxia
equivalent to 10,000 and 12,000 ft (3048 m and 3658 m, respectively),
but was unable at the time to analyse markers of bone turn-over, and
was inconclusive regarding phosphorus metabolism. There was partial
congruence regarding calcium excretion between studies, although the
sparing of bed rest-induced calcium excretion seems more pronounced
and longer-lasting in the study by Lynch et al.'s [10] study than in the
present one.
4.1. Bed rest effects
The salient features of bed rest-related alterations of bone metabo-
lismhave all been replicated in this study, namely increased bone resorp-
tion and reduced bone formation [33], increased excretion of calciumand
phosphate [34], loss of bone mineral from the lower extremities [2], de-
creased serum PTH [4], and increased serum levels of sclerostin andTable 3
Overview of statistical results for biological sample data. P-values for main effects of time
and hypoxia, and for time ∗hypoxia interaction, listed for bed rest data (columns 2–4), and
for hypoxic ambulatory data (HAmb column 5). Signiﬁcant effects are set in bold face, and
trends are marked with (T).
Bed rest Ambulatory
hypoxia




P1NP 0.004 0.18 0.88 0.97
bAP b0.001 0.43 0.97 0.016
Calcium b0.001 0.20 0.83 b0.001
PTH b0.001 0.045 b0.001 0.0013
P b0.001 0.96 0.73 b0.001
Sclerostin b0.001 0.73 0.61 0.002
DKK1 b0.001 0.0052 0.94 0.0057
Urinary excretion
NTX excretion b0.001 0.66 0.69 0.072 (T)
Calcium excretion b0.001 0.067 (T) 0.029 b0.001
Phosphate excretion b0.001 0.60 0.0010 b0.001DKK1 [35]. Notably, vitamin D had been supplemented throughout the
study. Accordingly, there is little reason to assume that D-deﬁciency,
which is quite commonnowadays in young people, had substantial inﬂu-
ence on these results. This study has also replicated the ﬁnding that bone
resorption, after an initial andmoderate increase on day 2 or 3 of bed rest
[36], is fully activated only around the 8th day (see Fig. 1 in [37], Fig. 2 in
[38] and Fig. 1 in this publication) – a ﬁnding that, although previously
published for experimental bed rest [38] and for spaceﬂight [37] has
been mostly ignored. Likely explanations involve time-delays in cellular
communication between osteoblasts and osteoclasts, in the activation
and maturation within the monocytic-osteoclastic lineage, as well as in
homing of osteoclastic cells in the bone matrix.
4.2. Responses to hypoxia
Overall, the present data do not suggest that normobaric hypoxia
equivalent to 4000 m per se would exaggerate bone resorption in
healthy humans. This is in stark contrast to the numerous in-vitro stud-
ies that demonstrate profound effects of hypoxia on osteoclasts, enhanc-
ing their differentiation from pre-cursor cells [20,39], modulating their
binding to resorption sites [20], and affecting their resorption activity
[39]. Moreover, expectations that hypoxia would hamper osteoclastic
activity through reduced sclerostin release [19] are not supported by
our results, as serum levels of sclerostin, as well as of DKK1 were
found to be increased during ambulatory hypoxic conditions (see
Fig. 3). Notably, increased sclerostin and DKK1 levels normally indicate
enhanced bone resorption [35,40]. There is no doubt about the effective-
ness of the hypoxic stimulus in this study (normobaric equivalent to
4000 m), as reﬂected in profound systemic hypoxemia (reduced SpO2)
noted in all participants throughout both hypoxic campaigns. The mag-
nitude of the SpO2 reduction is in line with previous studies investigat-
ing normobaric hypoxic exposures to the same simulated altitudes
[41]. Patients with moderate to severe COPD, who lack the ability of hy-
perventilation, are supposed to receive long term oxygen therapy
(LTOT) when their SpO2 b 88% or their PaO2 b 7.3 kPa [42]. Notably,
SpO2 was 88% in hypoxic conditions in this study. However, patients
with severe COPD develop pathologic retention of CO2 and concomitant
blood acidiﬁcation [13]. In contrast to that, subjects in this study even
lowered their arterial CO2 levels, which is the classic hyperventilation
response to high altitude.
Therefore, we discuss the possibility here that hypoxia-induced
hypocapnia in this study can explain part of the results. Hyperventila-
tion, i.e. lowering of PCO2 within the body through ventilatory dissipa-
tion of CO2, causes alkalization. This, in turn, causes immediate
reductions in serum concentrations of ionized, but not total calcium
[43]. Within minutes, this leads to lowering of serum phosphate levels
and moderate increases in serum calcium through intermediate effects
in tissuemetabolism [44]. Decreased phosphate levels in serum, and in-
creased calcium levels, as observed during the onset of hypoxic ambula-
tory conditions (Fig. 2) in this study are therefore in keepingwith these
purported short-term hyperventilation effects. However, the question
Fig. 1.Urinary excretion for normoxic and hypoxic bed rest (NBR and HBR, respectively) and for hypoxic ambulatory conﬁnement (HAmb). Excretion of the bone resorptionmarker NTX,
of calcium and of phosphate are plotted over time for baseline data collection (BDC), for intervention days (D, being either bed rest or ambulatory hypoxia) and for recovery days (R). Data
aremeans and their standarderrors.Main effects of bed rest (BR) are denoted as *P b 0.05; **P b 0.01; ***P b 0.001; BR*:Hypoxia interaction effects: iiP b 0.01; iiP b 0.001; time effects during
HAmb: +P b 0.05; ++P b 0.01; +++P b 0.001.
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the later stages (see Fig. 2). Whatever these mechanisms may be, it
seems possible to explain the nonappearance of exaggerated bone
resorption during hypoxic ambulatory conditions by compensatory
effects of hyperventilation-related alkalization.Fig. 2. Serum levels of bone formation marker P1NP, calcium, phosphate and PTH. Signiﬁca
*** (P b 0.001); signiﬁcant contrasts for time in HAmb data are denoted as + (P b 0.05), ++
rest data with P b 0.001 is denoted as iii.4.3. Alterations of bed rest responses by hypoxia
Interactions between bed rest and hypoxia were few and limited in
time. Speciﬁcally we observed: i) reduced phosphate excretion on the
1st and 2nd days of bed rest (Fig. 1), reduced calcium excretion on thent contrasts for time in the bed rest data are denoted as * (P b 0.05), ** (P b 0.01) and
(P b 0.01) and +++ (P b 0.001); a signiﬁcant time ∗ condition interaction effect for bed
136 J. Rittweger et al. / Bone 91 (2016) 130–1388th and 10th days (Fig. 1), and normalization of PTH levels that became
signiﬁcant on the 21st day of bed rest (Fig. 2). These three interaction
effects can be interpreted from Figs. 1 and 2 as linear superposition of
hypoxic effects onto bed rest effects (as evidenced e.g. by coinciding
‘+’ and ‘i’ symbols in Figs. 1 and 2).
Both sclerostin andDKK1 levelswere increased by bed rest aswell as
under hypoxic ambulatory conditions. While the former was expected
[35,45], the latter is in some contrast to results from in-vitro studies
[19]. Notably, the sclerostin elevations during hypoxic ambulatory con-
ditions in this studywere neither associatedwith decreased P1NP levels
nor with increased NTX excretion (Figs. 2 and 1, respectively). More-
over, hypoxia added onto bed rest did not lead to further increases in
sclerostin serum levels (lack of interaction effects in Fig. 3). The physio-
logical implications of sclerostin in hypoxic bone responses therefore
are currently not clear.4.4. Clinical implications
Arterial hypoxemia has been postulated to cause systemic in-
ﬂammation by activation of regulatory pathways and cytokines,
thus causing bone loss and musculoskeletal dysfunction [11].
While COPD is associated with cachexia and musculoskeletal
wasting [15], the present results suggest no effect of hypoxia on
disuse-induced bone losses. In contrast to our healthy subjects
who hyperventilated in the hypoxic conditions, and were conse-
quently most likely hypocapnic compared to the normoxic condi-
tion, COPD patients are both hypoxic and hypercapnic in normoxic
conditions [11]. Thus chronic acidiﬁcation of blood pH, which suppos-
edly could contribute to bone loss, is not seen in a healthy,
hyperventilating person. To add further argument to the notion of re-
spiratory effects on bone metabolism we refer to the sleep apnea syn-
drome. During the hypoxic trials, subjects experienced sleep apnea,
which resulted in a hypercapnic and a greater hypoxic stimulus, albeit
episodically. Notwithstanding, bone resorption is elevated in severe
cases of sleep apnea syndrome, and continuous positive airway pres-
sure therapy reverses this elevation [46].Fig. 3. Serum levels of Wnt-signalingmolecules sclerostin and DKK1. Signiﬁcant contrasts for ti
for time in HAmb data are denoted as ++ (P b 0.01) and +++ (P b 0.001).4.5. Implications for space ﬂight
There was no negative impact on bone metabolism by hypoxia in
this study, and both the present study as well as the one by Lynch et
al. [10] indicate potentially effects the risk of renal concrements in
space [47]. This indicates that changing spacecraft atmospheres from
sea level to 4000 m equivalents is unlikely to aggravate bone-related
risks in long-term space sojourns. However, this conclusion should be
taken with two important restrictions. Firstly, it should be considered
that elevated CO2 concentration, as typically present in spacecraft atmo-
spheres [48] could counteract the positive hyperventilatory effects sur-
mised above. Second, hypoxia interferes with the capacity to perform
aerobic exercise, and it can hamper muscular beneﬁts of resistive exer-
cise [49]. Thus, because there was no exercise involved in the bed rest
conditions of this study, one has to consider that hypoxia could negative-
ly impact upon efﬁcacy of exercise countermeasures that have proven
successful under normoxic conditions.4.6. Limitations
A few limitations of this study need to be considered. Firstly, its de-
sign is not full factorial, i.e. there was no speciﬁc normoxic ambulatory
campaign. To organize another campaign would have raised ﬁnancial,
organizational and ethical issues. To recruit suitable subjects for a 3-
campaign cross-over trial is by no means easy, and recruiting subjects
for a four-campaign trial was not feasible at this stage. However,
normoxic ambulatory conditions were present during the seven days
of baseline collection in all three campaigns. Thus, some of the informa-
tion that would emerge from a fourth, normobaric ambulatory cam-
paign is contained in the changes from baseline in the hypoxic
ambulatory campaign. Second, the sample size in this study was rela-
tively small, and thus with limited statistical power. A larger study
therefore might be able to ﬁnd more signiﬁcant effects. Third, subjects
in this study were younger than typical astronauts. Recent results sug-
gest that bonemetabolic responses to bed rest are comparable between
men in their 3rd and in their 6th decade of life (Buehlmeier et al.,me in the bed rest data are denoted as * (P b 0.05) and *** (P b 0.001); signiﬁcant contrasts
137J. Rittweger et al. / Bone 91 (2016) 130–138unpublished results), but older individuals might bemore vulnerable to
hypoxic exposures or hypoxic disease states than younger individuals
due to the blunted hypoxic ventilatory response [50]. While hypoxemic
systemic inﬂammation in COPD patients appears to be driven by white
adipose tissue [51], we do not suspect this mode of action in our young,
healthy individuals. Pulmonary remodeling as a known consequence of
hypoxia was not to be expected in our test population. It would there-
fore be highly interesting to repeat the experiment with subjects, who
often depict moderate levels of arterial hypoxemia, e.g.with older peo-
ple, in order to ﬁnd out whether reduced ventilatory compensation of
hypoxic challenges would cause more profound effects upon bone me-
tabolism. Fourth, this study has used normobaric hypoxia, which may
not fully represent the hypobaric hypoxia condition that is envisaged
in future spacecrafts. Finally it needs to be mentioned that pQCT results
in this studywere not very conclusive. This has to be assigned to the rel-
atively short duration (21 days), which turns out to be just long enough
to assess effects of bed rest, but probably not long enough to decipher
modulatory effects.
5. Conclusion
The present study refutes the idea of strong modulatory effects by
hypoxia upon bed rest-induced alterations in bone metabolism, at
least in young men. There was, however, a consistent and moderately
strong effect upon calcium homeostasis, with reductions in urinary ex-
cretion of calcium and phosphate. As these two compounds play a
major role in the formation of renal concrements, the present data
could imply a moderate mitigation effect for the known risk of renal
stone in bed rest [4] and spaceﬂight [47]. These beneﬁts are, however,
likely limited, as the effect was most pronounced in the initial half of
the bed rest period and faded away thereafter. Finally, the study also
demonstrates that hypoxia-induced perturbation of calcium metabo-
lism leaves bone resorption responses unaffected. This adds further ev-
idence to the understanding that BR-induced bone losses are mainly
driven by the mechanical environment, and are quite independent of
hormonal or endocrine changes.
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